D-1044-2019 Class II Terminated
FDA drug recall D-1044-2019 was initiated by AVKARE Inc. on Mar 5, 2019 and is designated Class II. Reason for recall: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified The recall status is terminated (terminated Dec 7, 2020).
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2019
- Initiation Date
- Mar 5, 2019
- Termination Date
- Dec 7, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 ---- NDC 50268-517-15
Reason for recall
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
Distribution pattern
Nationwide.
Code information
Lots: 20961 Exp. 09/2019; 20477 Exp. 08/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1044-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026